Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

September 16 - 18, 2026
Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

September 21, 2026 – Cambridge Innovation Center (CIC), 1 Broadway, 5th Floor, Havana Room | Cambridge, MA
Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

September 22 - 23, 2026 – Westin Copley Place | Boston, MA

All early clinical resources

Pharmacometrics Approach Group in Japan 2026​

Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference

Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions

Modeling and Simulation - PK/PD, Blog

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

Why pharmacometrics automation is the foundation of modern PK/PD

Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - MBMA, Case Study

The five drug development questions that bring sponsors to pharmacometrics

Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Blog

Beyond Trial and Error: Model-Informed Formulation Development in Practice

Certara Products - Simcyp, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Webinar

Model-Based Meta-Analysis (MBMA): Real-World Examples

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - MBMA, Fact Sheet

How to Choose Your First-in-Human Dose Approach

Certara Services, Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.